Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Resources plc Regulatory News (PANR)

Share Price Information for Pantheon Resources plc (PANR)

Share Price is delayed by 15 minutes
Get Live Data
13.52    -0.37 (-2.66%)
Bid:
13.51
Ask:
14.00
Spread: 0.49 (3.627%)
Market Cap: £197.11m
PANR Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Resources plc Share Chart

Dubhe-1 Operational Update

8 Oct 2025 07:00

RNS Number : 4607C
Pantheon Resources PLC
08 October 2025
 

 

 

 

8 October 2025

 

Pantheon Resources plc

 

Dubhe-1 Operational Update - Successful Completion of Fracture Stimulation Operations

 

Pantheon Resources plc ("Pantheon" or the "Company"), the oil and gas company developing the Kodiak and Ahpun projects immediately adjacent to pipeline and transportation infrastructure on Alaska's North Slope, is pleased to announce successful completion of the hydraulic fracture stimulation on the Dubhe-1 well.

 

Key Points

· 25 hydraulic fracture stimulation stages successfully completed in 8 days

· Operations are now underway to prepare well for clean-up and production testing

 

Completion Details

As previously announced, the Dubhe-1 lateral was successfully drilled to a total measured depth ("MD") of 15,800 feet ("ft"), logged and cased back to surface providing c. 5,200 ft of the wellbore entirely within the SMD-B target reservoir available for stimulation.

 

Operations commenced on 30 September 2025 with equipment and personnel being mobilised from Alaska, Canada and the US Lower 48 states. The stimulation consisted of 25 individual "plug and perforate" stages of approximately 200 ft each. The programme proceeded in line with expectation with full placement of both water and sand. There were no spills or safety incidents of any kind during this operation. This represents an excellent result given Pantheon's limited prior experience treating this specific reservoir and utilising a full set of new contractors, including some that had not previously worked in Alaska. 

 

Over the coming weeks, the plugs set in the wellbore to separate the fracture simulation stages will be drilled out with coiled tubing, and 2-7/8 inch production tubing will be installed. The well will then be connected to a temporary well testing system for the commencement of flow testing operations. The Company expects to release further information, in line with its regulatory requirements, as the programme proceeds.

 

Erich Krumanocker, Chief Development Officer, said: "We are extremely pleased with the success of the operations so far. The team did an excellent job executing this large and intricate operation safely and efficiently. The stimulation was performed as planned, increasing our confidence in achieving the objectives of the forthcoming flow testing programme."

 

 

Further information:

 

Pantheon Resources plc

David Hobbs, Chairman

Max Easley, CEO

Justin Hondris, SVP, Investor Relations

contact@pantheonresources.com

 

Canaccord Genuity Limited (Nominated Adviser, and Joint Broker)

Henry Fitzgerald-O'Connor

James Asensio

Charlie Hammond

+44 20 7523 8000

 

 

Oak Securities (Joint Broker)

+44 20 3973 3678

Jerry Keen

Nick Price

 

BlytheRay (Corporate Communications)

+44 20 7138 3204

Tim Blythe

Megan Ray

Matthew Bowld

 

MZ Group (USA Investor Relations Contact)  

Lucas Zimmerman

Ian Scargill

 

+1 949 259 4987

 

 

About Pantheon Resources

Pantheon Resources plc is an AIM listed Oil & Gas company focused on developing its 100% owned Ahpun and Kodiak fields located on State of Alaska land on the North Slope, onshore USA. Independently certified best estimate contingent recoverable resources attributable to these projects currently total c. 1.6 billion barrels of ANS crude and 6.6 Tcf of associated natural gas. The Company owns 100% working interest in c. 259,000 acres.

 

Pantheon's stated objective is to demonstrate sustainable market recognition of a value of approximately $5 of recoverable resources by end 2028. This is based on bringing the Ahpun field forward to FID and producing into the TAPS main oil line (ANS crude) by the end of 2028. The Gas Sales Precedent Agreement signed with AGDC provides the potential for Pantheon's natural gas to be produced into the proposed 807 mile pipeline from the North Slope to Southcentral Alaska during 2029. Once the Company achieves financial self-sufficiency, it will apply the resultant cashflows to support the FID on the Kodiak field planned, subject to regulatory approvals, targeted by the end of 2028 or early 2029.

 

A major differentiator to other ANS projects is the close proximity to existing roads and pipelines which offers a significant competitive advantage to Pantheon, allowing for shorter development timeframes, materially lower infrastructure costs and the ability to support the development with a significantly lower pre-cashflow funding requirement than is typical in Alaska. Furthermore, the low CO2 content of the associated gas allows export into the planned natural gas pipeline from the North Slope to Southcentral Alaska without significant pre-treatment.

 

The Company's project portfolio has been endorsed by world renowned experts. Netherland, Sewell & Associates estimate a 2C contingent recoverable resource in the Kodiak project that total 1,208 mmbbl of ANS crude and 5,396 bcf of natural gas. Cawley Gillespie & Associates estimate 2C contingent recoverable resources for Ahpun's western topset horizons at 282 mmbbl of ANS crude and 803 bcf of natural gas. Lee Keeling & Associates estimated possible reserves and 2C contingent recoverable resources of 79 mmbbl of ANS crude and 424 bcf natural gas.

 

For more information visit www.pantheonresources.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFDLLBEBLFFBF
Date   Source Headline
14th Dec 20237:04 amRNSSuccessful Acquisition of Leases
12th Dec 20237:00 amRNSAppointment of Independent Non-Executive Director
21st Nov 20234:36 pmRNSStrategy Update
15th Nov 20231:54 pmRNSInvestor Presentation via Investor Meet Company
14th Nov 202311:56 amRNSBond Payment, Placement & Corporate Update
19th Oct 20237:00 amRNSValidation of frac design and fluid sampling
18th Oct 20237:00 amRNSPantheon Presenting at OTC Oil and Gas Conference
4th Oct 20237:00 amRNSReplacement TR-1: Notification of major holdings
3rd Oct 20234:02 pmRNSTR-1: Notification of major holdings
27th Sep 20237:00 amRNSCommencement of Operations - Re-entry of Alkaid-2
14th Sep 20233:34 pmRNSWebinar and update
8th Sep 20238:20 amRNSInvestor Presentation Webinar
7th Sep 20237:00 amRNSPrivate Placement
30th Aug 20237:00 amRNSDirector/PDMR Notification
29th Aug 20237:00 amRNSExpert Report Confirms Estimate for Kodiak Field
28th Jul 20237:57 amRNSReplacement Operational Update
28th Jul 20237:00 amRNSOperational Update
14th Jul 20239:30 amRNSInvestor Presentation via Investor Meet Company
10th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Jul 20238:53 amRNSAppointment of Independent Non-Executive Director
28th Jun 20234:58 pmRNSWebinar and Strategy Update
26th Jun 202312:54 pmRNSUpcoming Webinar - Registration Details
15th Jun 20233:50 pmRNSIssue of Equity and Total Voting Rights
8th Jun 20237:00 amRNSAppointment of Executive Chairman
1st Jun 20237:00 amRNSLease Award
23rd May 20234:32 pmRNSUpdate on Fundraise
18th May 20235:40 pmRNSBlock Listing Six Monthly return
17th May 20237:00 amRNSResult of Capital Raise
16th May 20235:07 pmRNSRetail Offer via PrimaryBid
16th May 20234:59 pmRNSProposed Placing and Subscription
21st Apr 20237:00 amRNSOperational and corporate update
31st Mar 20237:00 amRNSUnaudited Interim Results
22nd Mar 20235:09 pmRNSResult of AGM
20th Mar 20234:45 pmRNSAGM update
20th Mar 20237:00 amRNSAGM webinar & corporate update
16th Mar 20232:08 pmRNSUpcoming Webinar – Registration Details
13th Mar 20233:33 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
9th Mar 202312:17 pmRNSAppointment of Independent Non-Executive Director
6th Mar 20237:00 amRNSOperational and corporate update
21st Feb 20236:06 pmRNSAnnual General Meeting & Webinar
21st Feb 20237:00 amRNSOperational update, PDMR & Issue of Equity
16th Feb 20237:00 amRNSAlkaid #2 update – well cleanout completed
10th Feb 20237:00 amRNSAlkaid #2 update
24th Jan 20231:49 pmRNSAlkaid #2 webinar and update
23rd Jan 20237:00 amRNSUpcoming Webinar - Registration Details
13th Jan 202311:03 amRNSConfirmation of Upcoming Webinar
3rd Jan 20237:00 amRNSInvestor Q&A
30th Dec 20227:00 amRNSOperational update
30th Dec 20227:00 amRNSFinal Results for the Year Ended 30 June 2022
14th Dec 20225:00 pmRNSQuarterly Repayment of Unsecured Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.